Bank of America
HAE icon

Bank of America’s Haemonetics HAE Stock Holding History

Bank of America’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-34,400
Closed -$1.82M – 8449
2021
Q4 		$1.82M Buy
+34,400
New +$2.1M ﹤0.01% 4654

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America's HAE Position: Q1 2026 in Review

Bank of America increased its Haemonetics (HAE) stake by 6.2% in Q1 2026, buying an estimated $1.96M and bringing the position to 512,183 shares worth $28.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

Bank of America first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $50.7M in Q2 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Bank of America held 512,183 shares of Haemonetics worth $28.9M as of Q1 2026.
  • Bank of America bought 30,018 Haemonetics shares in Q1 2026, an estimated $1.96M.
  • Haemonetics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2077 holding.
  • Bank of America first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Haemonetics position peaked at $50.7M in Q2 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.